InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,412.63
(
0.26%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

adreamer

Send PM Follow Ignore
Followers 2
Posts 1530
Boards Moderated 0
Alias Born 12/18/2010

adreamer

Re: BiotechGuy49 post# 24507

Sunday, 12/16/2012 9:57:46 AM

Sunday, December 16, 2012 9:57:46 AM

Post# of 80490
It's hard to imagine that the brain trust on this board...can evaluate the study data...and understand it and that the analysts can't...Given the hard statistics in the response data Ponatinib will outperform current drugs in a first use setting...period...end of story....So if your an analyst and you understand the huge potential in front line...how the hell are you worrying about 2nd or 3rd line uptake...Is this board... THAT.. ahead of the curve ?....
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up